FRI0366 Primary respiratory disease in patients with systemic lupus erythematosus: data from the spanish rheumatology society lupus registry (RELESSER) cohort. (12th June 2018)

• Record Type: Journal Article
• Authors: Narvaez, J.; Borrell, H.; Sánchez-Alonso, F.; Rúa-Figueroa, I.; Lopez-Longo, F.J.; Galindo, M.; Calvo-Alen, J.; Fernández-Nebro, A.; Olivé, A.; Andreu, J.L.; Blanco, R.; Andres, M.; Alegre, J.J.; Cobo-Ibañez, T.; Bonilla, G.; Boteanu, A.; Díez-Álvarez, E.; Freire, M.; Gantes, M.; Garcia de la Peña, P.; Garcia-Vicuña, R.; Hernández Beiraín, J.; Horcada, M.L.; Ibañez, J.; Juan Mas, A.; Lozano-Rivas, N.; Marenco, J.L.; Castelvi, I.; Montilla-Morales, C.; Moreno, M.; Pecondon-Español, A.; Ruiz Lucea, E.; Sanchez-Atrio, A.; Santos-Soler, G.; Toyos, F.; Uriarte Isacelaya, E.; Vazquez-Rodriguez, T.R.; Nolla, J.M.; Pego-Reigosa, J.M.;
• Is Part Of: Annals of the rheumatic diseases. Volume 77(2018)Supplement 2
• Page Start: 718
• Page End: 718
• Publication Date: 2018-06-12
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2018-eular.6436
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Objectives: To investigate the primary respiratory manifestations (PRM) in SLE. Methods: All patients in the RELESSER cohort were retrospectively investigated for the presence of PRM Results: At least one PRM was present in 11.3% (365/3215) of cases. The most common was pleurisy, occurring in 21.1% of patients, followed by ALP in 3.6%, PE in 2.9%, PPH 4%, DILD in 2%, DAH in 0.8%, and SLS in 0.8%. The variables associated with the presence of PPM are shown in the following table 1: Conclusions: PPM independently contributed to a decreased survival in SLE Disclosure of Interest: None declared